AML

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2147514
                    [Title] => Entities without AML plans face fines Lawrence agcaoili
                    [Summary] => Covered entities that fail to submit anti-money laundering plans on time face hefty fines from the country’s sole financial intelligence unit, according to the Anti-Money Laundering Council.
                    [DatePublished] => 2021-12-13 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 620387
                    [Title] => Molecular targets of cancer as basis for new drugs and immunotherapy
                    [Summary] => 
A few months ago, in this column I wrote about a close friend who has  survived AML (acute myeloid leukemia) for more than 10 years. It was in  an article on “Anticancer drugs from land and sea.” 
                    [DatePublished] => 2010-10-14 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1339989
                    [AuthorName] => Gisela Padilla-Concepcion, PhD
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Entities without AML plans face fines Lawrence agcaoili

December 13, 2021 - 12:00am

Covered entities that fail to submit anti-money laundering plans on time face hefty fines from the country’s sole financial intelligence unit, according to the Anti-Money Laundering Council.

Business

Molecular targets of cancer as basis for new drugs and immunotherapy

By Gisela Padilla-Concepcion, PhD | October 14, 2010 - 12:00am

A few months ago, in this column I wrote about a close friend who has survived AML (acute myeloid leukemia) for more than 10 years. It was in an article on “Anticancer drugs from land and sea.”

Science and Environment